Chronic lymphocytic leukemia (CLL) is the most common type of leukemia and the anti-CD20 monoclonal antibody, rituximab, represents the therapeutic gold standard for more than 2 decades ...
Tumor cell mediated immune-suppression remains a question of interest in tumor biology. In this study, the authors focused on the metabolites that are released by prostate cancer cells ...
The Society for Immunotherapy of Cancer (SITC) Primer on Tumor Immunology and Cancer ImmunotherapyTM - From Biology to Treatment
June 1, 2012
Hyatt Regency McCormick Place
From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer ...
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org